Movement Disorder Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026

Published on : Nov-2017 | List of Tables : 131 | List of Figures : 81 | No. of Pages : 170 | Report Code : FACT329MR | Format :

Prevalence of the mental disorders has continued to remain high among the old aged population globally. Neurological diseases such as Huntington’s disease, Parkinson’s disease and multiple symptom atrophy (MSA) continues to propel demand for management of the movement disorders. Lack of production of brain chemical dopamine by the nerve cells in the brain leads to uncoordinated movements and mental disorders that impact the everyday activities of the persons.

global movement disorder market

According to Fact.MR, the global movement disorder market is expected to represent a value of over US$ 1,000 Mn by the end of 2026.

Market Taxonomy

Region

Product Type

End User

Application Type

North America

Rechargeable Deep Brain Stimulator Devices

Hospitals

Parkinson's Disease

Latin America

Non-rechargeable Deep Brain Stimulator Devices

Ambulatory Surgical Centers

Essential Tremor

Europe

 

Clinics

Dystonia

Japan

   

Refractory Epilepsy

APEJ

   

Obsessive Compulsive Disorder

MEA

     

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

For more insights, request sample of this report.

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases. Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking. Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results. Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization. Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market. In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

Parkinson ’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Request research methodology of this report.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Growing prevalence of the neurological diseases is expected to contribute towards growth of the global movement disorder market. As manufacturers are increasingly focusing on development and innovation of products, growth of the global market is expected to remain positive. This Fact.MR report analyzes the expansion of global movement disorder market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global movement disorder market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global movement disorder market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to movement disorder.

Summary

The report commences with a brief information of the global movement disorder market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global movement disorder market.

Overview

The next section offers an overview of the global movement disorder market. This comprises an introduction to the market, along with a standard definition of the product – movement disorder. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global movement disorder market, the report provides updates about market opportunities, which can benefit leading manufacturers of movement disorder. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for movement disorder manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global movement disorder market. Product type, end user, application, and region are key segments that define the growth of the global market for movement disorder. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global movement disorder market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global movement disorder market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis

Chapter 1 Global Outlook

Chapter 2 Global Movement Disorder Market - Executive Summary

Chapter 3 Global Movement Disorder Market Overview
3.1 Introduction
      3.1.1 Global Movement Disorder Market Taxonomy
      3.1.2 Global Movement Disorder Market Definition
3.2 Global Movement Disorder Market Size (US$ Mn) and Forecast, 2012-2026
      3.2.1 Global Movement Disorder Market Y-o-Y Growth
3.3 Global Movement Disorder Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 Technology Roadmap
3.7 Disease Epidemiology
3.8 Product Lifecycle
3.9 Key Regulations
3.10 PESTL Analysis
3.11 List of Service Providers
3.12 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Movement Disorder Market Analysis and Forecast 2012-2026
4.1 Global Movement Disorder Market Size and Forecast by Product Type, 2012-2026
      4.1.1 Rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Non-rechargeable Deep Brain Stimulator Devices Market Size and Forecast, 2012-2026
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Movement Disorder Market Size and Forecast by End User, 2012-2026
      4.2.1 Hospitals Market Size and Forecast, 2012-2026
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Ambulatory Surgical Centers Market Size and Forecast, 2012-2026
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Clinics Market Size and Forecast, 2012-2026
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
4.3 Global Movement Disorder Market Size and Forecast by Application Type, 2012-2026
      4.3.1 Parkinson's disease Market Size and Forecast, 2012-2026
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Essential Tremor Market Size and Forecast, 2012-2026
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region
      4.3.3 Dystonia Market Size and Forecast, 2012-2026
              4.3.3.1 Revenue (US$ Mn) Comparison, By Region
              4.3.3.2 Market Share Comparison, By Region
              4.3.3.3 Y-o-Y growth Comparison, By Region
      4.3.4 Refractory Epilepsy Market Size and Forecast, 2012-2026
              4.3.4.1 Revenue (US$ Mn) Comparison, By Region
              4.3.4.2 Market Share Comparison, By Region
              4.3.4.3 Y-o-Y growth Comparison, By Region
      4.3.5 Obsessive Compulsive Disorder Market Size and Forecast, 2012-2026
              4.3.5.1 Revenue (US$ Mn) Comparison, By Region
              4.3.5.2 Market Share Comparison, By Region
              4.3.5.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Movement Disorder Market Size and Forecast, 2012-2026
5.1 Revenue (US$ Mn) Comparison, By Country
5.2 Revenue (US$ Mn) Comparison, By Product Type
5.3 Revenue (US$ Mn) Comparison, By End User
5.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 6 Latin America Movement Disorder Market Size and Forecast, 2012-2026
6.1 Revenue (US$ Mn) Comparison, By Country
6.2 Revenue (US$ Mn) Comparison, By Product Type
6.3 Revenue (US$ Mn) Comparison, By End User
6.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 7 Europe Movement Disorder Market Size and Forecast, 2012-2026
7.1 Revenue (US$ Mn) Comparison, By Country
7.2 Revenue (US$ Mn) Comparison, By Product Type
7.3 Revenue (US$ Mn) Comparison, By End User
7.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 8 Japan Movement Disorder Market Size and Forecast, 2012-2026
8.1 Revenue (US$ Mn) Comparison, By Country
8.2 Revenue (US$ Mn) Comparison, By Product Type
8.3 Revenue (US$ Mn) Comparison, By End User
8.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 9 APEJ Movement Disorder Market Size and Forecast, 2012-2026
9.1 Revenue (US$ Mn) Comparison, By Country
9.2 Revenue (US$ Mn) Comparison, By Product Type
9.3 Revenue (US$ Mn) Comparison, By End User
9.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 10 MEA Movement Disorder Market Size and Forecast, 2012-2026
10.1 Revenue (US$ Mn) Comparison, By Country
10.2 Revenue (US$ Mn) Comparison, By Product Type
10.3 Revenue (US$ Mn) Comparison, By End User
10.4 Revenue (US$ Mn) Comparison, By Application Type

Chapter 11 Global Movement Disorder Market – Competitive Landscape and Company Profiles
11.1 Global Movement Disorder Market – Company Share Analysis
11.2 Global Movement Disorder Market – Competitive Landscape
11.3 Global Movement Disorder Market – Company Profiles
      11.3.1 Medtronic Plc
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Abbott Laboratories Inc
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
              11.3.2.3 Key Financials
              11.3.2.4 Key Developments
              11.3.2.5 SWOT Analysis
      11.3.3 Boston Scientific Corporation
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Mayo Clinic
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview

Chapter 12 Fact.MR Research Methodology

Chapter 13 Disclaimer

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Movement Disorder Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2017 to 2026